Autism spectrum disorders is one of the commonest developmental disabilities that is seen in clinical practice. There have been a number of new interventions that have been posited to be useful in the management of autism spectrum disorders. This has resulted in the need for sound clinical trials using these interventions in management of children with the condition. The present paper provides an overview of the various ethical issues that arise when conducting clinical trials in children with autism spectrum. Issues like informed consent, legally acceptable representative and safety have been discussed. The paper will serve as a primer for those working in the area and even undertaking clinical trials in this population.
No takes yet. Share an insight, caveat, or question.
Nisarga et al. (2022) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: